Compared with those in the PBS group, the severity of joint swelling and arthritis score was significantly lower in the OE-NC MSC group, whereas the therapeutic efficacy in the OE-HDAC5-MSC group surpassed that in the OE-NC-MSC group (Fig. 5B, C). This evidence concerns the gene HDAC5 and arthritic joint disease.